How ChatGPT is Transforming the Future of the Pharma Industry

The recent rise of generative Artificial Intelligence (AI) has revolutionized the approach to innovative solutions for the Life Sciences industry. ChatGPT (GPT-4), an advanced large language model powered by AI, may have the ability to greatly benefit the pharmaceutical industry. With its ability to understand and generate human-like text, the industry may one day be able to leverage ChatGPT to streamline operations, enhance R&D efforts, improve customer support, and aid in regulatory compliance.

(more…)

PM360: Four Key Questions About Data Analytics

PM360 asked experts in data analytics about how the process behind collecting and analyzing data is changing, including these four key questions:

  • How is the advancement of artificial intelligence, natural language processing, machine learning, and deep learning impacting the data analytics landscape?
  • How has the rise of concern for data privacy and the implementation of the EU’s General Data Protection Regulation (GDPR) affected pharma’s ability to collect or use data?
  • What can organizations do to help make their employees more data literate? Ultimately, how do you make everyone comfortable using data analytics?
  • What is the future of data analytics? How else is data collection, analyzation, visualization, implementation, etc., likely to change in 2019 and beyond?
(more…)

Big Pharma; Big Data: How a third party can revolutionize your data for a better tomorrow

As each industry becomes more technologically savvy, the pharmaceutical industry has the chance to emerge into the 21st century and reform how they treat patients while tackling different medical epidemics that affect the world today.

(more…)

RxDataScience, Inc. accepted into Forbes New York Business Council

Forbes New York Business Council Is an Invitation-Only Community for Small Business Owners in Greater New York City

(more…)

RxDataScience Enters Into Joint AI Research Venture with Indian Institute of Technology Mandi

RxDataScience and the Indian Institute of Technology Mandi have announced an 18-month long research venture. The partnership has a twofold goal: to both design and develop AI applications for rare disease treatment and use machine learning prediction models for different measures of interest to improve upon patient journeys. 

(more…)

RxDataScience, Inc. Named Top 30 Fastest Growing Company

The Silicon review has selected RxDataScience as a "Top 30 Fastest Growing Companies to Watch" in 2017. The award signifies rapid growth in revenue and meaningful customer acquisition, as well as headcount growth and potential for disruption in a large market or creation of a new market.

(more…)

Applying Data Science and Predictive Analytics to the Healthcare Data for Improving Patient Outcomes and Lowering Costs

“Our vision is to apply data science to healthcare data to improve patient lives worldwide. The focus is on applying advanced predictive statistical techniques to either very large or very complex healthcare data sets. The

(more…)

Kx technology to support RxDS as it moves to disrupt healthcare and pharma analytics market

Kx selected by RxDS as the platform for its data analytics solutions. Solutions based on Kx will unlock the data within pharma and healthcare companies to allow better and more rapid decisions. RxDS aims to disrupt

(more…)